The PublicAffairsAsia network and magazine has hosted its first China healthcare policy and communications event where over 80 senior healthcare policy and communications executives met in Shanghai.
The expert practitioners debated and discussed the changing Chinese healthcare policy landscape, examining the impact for corporate government relations, public affairs and communications professionals.
A wide range of pharmaceutical, healthcare, medical technology and nutrition policy and communications experts from companies including Bristol-Myers Squibb, BUPA, Chindex, Cook Medical, Motorola Solutions China, Deloitte Consulting and Cochlear attended and participated in the full day event.
Focusing on both policy and practice, Health of a Nation: New Prescriptions for China was an interactive event forming part of the new sectoral PublicAffairsAsia “Active” series and was supported by lead sponsor APCO Worldwide.
The event was moderated by Professor Bill Valentino, Director of the Institute of Social Responsibility at Beijing Normal University, a leading heath literacy expert.
The event heard from a range of speakers including Dr. Zhang Junhua, Deputy Director-General, the Health Human Resources Development Center at, the Ministry of Health; Stella Ling, Vice President of Public Affairs, Bristol-Myers Squibb; Daniel Brindle, Senior Director, International Public Affairs & Policy (Asia) at Pfizer and Francis Cao, Senior Director of Government Affairs and Public Relations, Beigene.
Commenting, Mark O’Brien, PublicAffairsAsia, Vice-President, said: “ PublicAffairsAsia, in association with APCO Worldwide, were delighted to host this event to examine the fundamental challenges and opportunities within the healthcare arena, as well as explore how communications, regulatory and corporate public affairs practitioners can help support China’s continued progress in the provision of better healthcare.”
Ken Jarrett, Chairman of APCO Worldwide, China, said: “During the forum, we heard from a diverse array of guests and participants to help advance our understanding of China’s healthcare arena, shared first-hand experiences and expertise, and offered candid insights into how we can help each other both advance our professional objectives as well as contribute to the improvement of the health of Chinese citizens.”
Partners for the high-level event included AmCham Shanghai, The China Britain Business Council, The US China Business Council, The Confederation of British Industry and The Wall Street Journal.